Journal article
Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms
Herve Ghesquieres, Guillaume Cartron, John Francis Seymour, Marie-Helene Delfau-Larue, Fritz Offner, Pierre Soubeyran, Aurore Perrot, Pauline Brice, Reda Bouabdallah, Anne Sonet, Jehan Dupuis, Olivier Casasnovas, John Vincent Catalano, Alain Delmer, Fabrice Jardin, Aurelie Verney, Peggy Dartigues, Gilles Salles
Blood | AMER SOC HEMATOLOGY | Published : 2012
Grants
Funding Acknowledgements
This work was supported in part by a grant from the Institut National du Cancer (INCa, Paris, France) French Ministry of Health.